Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label study

Haematologica 2026 Open access

Read full text
Authors: Geoffrey Z.L. Kuppens, Maria Armila D. Ruiz, M. Van Dijk, Minke A. E. Rab, Cleo Derichs, Joline L. Saes, Anita W. Rijneveld, Marjon Cnossen, Erfan NUR, Bart J. Biemond, Marije Bartels, Santosh L. Saraf
+1 more Eduard Johannes van Beers
DOI: 10.3324/haematol.2025.289105
Cited by: 1

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Blood groups and transfusion Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Volume
111
Issue
8
Pages
2792–2796
Publication date
26 February 2026
Language
EN